Table 5.
Logistic regression analysis of factors associated with COVID-19-related symptoms within the pandemic cancer populations.
| Cancer Population | Unadjusted Analysis | p-Value | Adjusted Analysis | p-Value |
|---|---|---|---|---|
| Age | 1.01 (0.996–1.024) | 0.1683 | 1.012 (0.997–1.027) | 0.1199 |
| Sex | ||||
| Female | 1.129 (0.713–1.788) | 0.6057 | 1.021 (0.633–1.647) | 0.9324 |
| Male | ref | ref | ||
| HIV status | ||||
| Negative | 1.049 (0.678–1.621) | 0.8312 | 0.924 (0.568–1.503) | 0.7498 |
| Positive | ref | ref | ||
| Received TB vaccination | ||||
| Yes | 2.602 (1.198–5.652) | 0.0157 | 2.511 (1.114–5.661) | 0.0264 |
| No | ref | ref | ||
| SARS-CoV-2 seroprevalence | ||||
| Yes | 0.755 (0.488–1.166) | 0.2052 | 0.702 (0.449–1.098) | 0.1213 |
| No | ref | ref | ||
| Household size | 0.975 (0.905–1.050) | 0.4973 | 0.977 (0.905–1.054) | 0.5478 |
Note: TB denotes tuberculosis.